MX9704043A - Surtido de farmaco de liberacion sostenida empleando una goma de hidrocoloide en polvo obtenible a partir de plantas superiores. - Google Patents

Surtido de farmaco de liberacion sostenida empleando una goma de hidrocoloide en polvo obtenible a partir de plantas superiores.

Info

Publication number
MX9704043A
MX9704043A MX9704043A MX9704043A MX9704043A MX 9704043 A MX9704043 A MX 9704043A MX 9704043 A MX9704043 A MX 9704043A MX 9704043 A MX9704043 A MX 9704043A MX 9704043 A MX9704043 A MX 9704043A
Authority
MX
Mexico
Prior art keywords
hydrocoloid
assortment
pharmacy
superior plants
drug
Prior art date
Application number
MX9704043A
Other languages
English (en)
Other versions
MXPA97004043A (es
Inventor
Eric H Kuhrts
David R Friend
Syed A Altaf
Karen Yu
Jagdish Parasrampuria
Original Assignee
Cibus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cibus Pharmaceuticals Inc filed Critical Cibus Pharmaceuticals Inc
Publication of MXPA97004043A publication Critical patent/MXPA97004043A/es
Publication of MX9704043A publication Critical patent/MX9704043A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composicion farmacéutica de surtido oral para obtener liberacion sostenida de un fármaco en un mamífero; la composicion incluye (a) una cantidad adecuada de una goma hidrocoloide aceptable farmacéuticamente obtenible de plantas superiores (por ejemplo, aproximadamente 20% - 90% en peso), (b) otro excipiente (por ejemplo, aproximadamente 5% - 30% en peso) que ayuda en la liberacion sostenida y (c) una cantidad efectiva terapéuticamente de un fármaco; preferiblemente el tamaño de partícula medio de la goma es de aproximadamente 150æ o menos; se describe también un procedimiento para preparar la composicion y un método para obtener liberacion sostenida de un fármaco administrando la composicion a un sujeto en necesidad del mismo.
MX9704043A 1994-12-01 1995-11-30 Surtido de farmaco de liberacion sostenida empleando una goma de hidrocoloide en polvo obtenible a partir de plantas superiores. MX9704043A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34851594A 1994-12-01 1994-12-01
US348515 1994-12-01
PCT/US1995/015593 WO1996016638A1 (en) 1994-12-01 1995-11-30 Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants

Publications (2)

Publication Number Publication Date
MXPA97004043A MXPA97004043A (es) 1998-02-01
MX9704043A true MX9704043A (es) 1998-02-28

Family

ID=23368363

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9704043A MX9704043A (es) 1994-12-01 1995-11-30 Surtido de farmaco de liberacion sostenida empleando una goma de hidrocoloide en polvo obtenible a partir de plantas superiores.

Country Status (9)

Country Link
EP (1) EP0793485A4 (es)
JP (1) JPH10509981A (es)
CN (1) CN1172429A (es)
AU (1) AU709413B2 (es)
CA (1) CA2205351A1 (es)
FI (1) FI972304A7 (es)
MX (1) MX9704043A (es)
NO (1) NO972486L (es)
WO (1) WO1996016638A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
IL119627A (en) * 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
EP0974343B1 (en) * 1998-07-22 2004-09-29 Pharma Pass II LLC Process for manufacturing a solid metoprolol composition
EP0987020A1 (en) * 1998-09-04 2000-03-22 Pharma Pass LLC Metoprolol composition and processes for manufacturing the same
SE0003125D0 (sv) * 2000-09-05 2000-09-05 Astrazeneca Ab Modified polymers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1327938A (en) * 1969-12-17 1973-08-22 Sucrest Corp Composition for use in forming tablets
DE2130545A1 (de) * 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmazeutischer Formkoerper
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
EP0676967A4 (en) * 1992-12-30 1996-10-02 Fmc Corp RELEASED, EXTENDED, EASY TO PRODUCE EXCIPIENT, BASED ON KONJAC GLUCOMANNANE.

Also Published As

Publication number Publication date
FI972304A0 (fi) 1997-05-30
NO972486L (no) 1997-07-31
WO1996016638A1 (en) 1996-06-06
AU709413B2 (en) 1999-08-26
NO972486D0 (no) 1997-05-30
EP0793485A1 (en) 1997-09-10
FI972304L (fi) 1997-05-30
AU4372096A (en) 1996-06-19
CA2205351A1 (en) 1996-06-06
FI972304A7 (fi) 1997-05-30
CN1172429A (zh) 1998-02-04
EP0793485A4 (en) 1998-08-26
JPH10509981A (ja) 1998-09-29

Similar Documents

Publication Publication Date Title
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
IT1282352B1 (it) Composizione farmaceutica, in particolare essiccata mediante congelamento, per somministrazione orale di ondansetron e metodo per
AR006598A1 (es) "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
BR9916224A (pt) Forma de dosagem farmacêutica oral, processos para a manufatura de uma forma de dosagem fixa, para o tratamento e a profilaxia de distúrbios gastrintestinais e para evitar efeitos colaterias gastrintestinais, uso de uma forma de dosagem, combinação, e, embalagem tipo ampola
DK0831791T3 (da) Transport af lægemiddelstoffer til den nedre gastrointestinalkanal
AR037239A1 (es) Composicion de valdecoxib de desintegracion intraoral, proceso para su preparacion, tableta que se obtiene y el uso de dicha composicion en la preparacion de un medicamento.
DE60032749D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
BR9810124A (pt) Um itraconazol exibindo solibilidade incrementada, o método de preparação do mesmo e a composição farmacêutica para administração oral contendo o mesmo
AR027034A1 (es) Composicion para dosis oral de liberacion extendida
AP2003002763A0 (en) Controlled release formulations for oral administration
AR011919A1 (es) FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA
ATE375789T1 (de) Orales abgabesystem mit einem antibakteriellen und einem entzündungshemmenden mittel
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
MX9704043A (es) Surtido de farmaco de liberacion sostenida empleando una goma de hidrocoloide en polvo obtenible a partir de plantas superiores.
AR035006A1 (es) Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento.
PE20011113A1 (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina
MX9704079A (es) Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores.
BR0014440A (pt) Formulações de liberação controlada oral
AU1452402A (en) Novel pharmaceutical formulation in the form of cellulose capsules suitable for benzimidazole derivatives
CO5170463A1 (es) Formas polimorfas de un citrato de azobiciclo [2,2,2]octan- 3-amina y sus composiciones farmaceuticas
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel